Stocks › INCY

INCYTE CORP

INCY·Nasdaq·United States United States·USD
$114.63
-1.25 (-1.07%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
INCY
INCYTE CORP · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INCYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of INCY by members of U.S. Congress · 42 on record · 6 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Nov 5, 2026 Oct 7, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Apr 7, 2026 Mar 10, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Apr 7, 2026 Mar 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Stock Purchase
$1,001 - $15,000
Jun 10, 2025 May 19, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA INCYINCYTE CORP · Stock Sale
$1,001 - $15,000
May 31, 2025 May 15, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Mar 6, 2025 Feb 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Feb 6, 2025 Jan 17, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Jan 8, 2025 Dec 18, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Dec 5, 2024 Nov 15, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Oct 4, 2024 Sep 9, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Stock Sale
$1,001 - $15,000
Oct 4, 2024 Sep 9, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Sep 6, 2024 Aug 2, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Sep 6, 2024 Aug 2, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
May 6, 2024 Apr 23, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
May 6, 2024 Apr 26, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Stock Purchase
$1,001 - $15,000
Apr 5, 2024 Mar 25, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Jan 4, 2024 Dec 4, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Stock Sale
$1,001 - $15,000
Nov 8, 2023 Oct 10, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Nov 8, 2023 Oct 2, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Sale
$1,001 - $15,000
Oct 6, 2023 Sep 6, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Common Stock Purchase
$1,001 - $15,000
Jul 11, 2023 Jun 26, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA INCYINCYTE CORP · Stock Purchase
$1,001 - $15,000
Jul 11, 2023 Jun 29, 2023 Filing ↗

Whale Activity

Position changes in INCY reported for 2026-09-30 by 979 institutional filers
Increased: 359New: 130Held: 114Decreased: 258Closed: 74No prior filing: 44
  • Increased359
  • New130
  • Held114
  • Decreased258
  • Closed74
  • No prior filing44
FilerSharesValueChange
BAKER BROS. ADVISORS LP30.8M$3.73Bincreased
BlackRock, Inc.19.1M$2.32Bincreased
VANGUARD CAPITAL MANAGEMENT LLC11.2M$1.36Bincreased
DODGE & COX10.1M$1.22Bdecreased
STATE STREET CORP9.9M$1.20Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC7.8M$943.3Mdecreased
AQR CAPITAL MANAGEMENT LLC5.6M$677.4Mincreased
GEODE CAPITAL MANAGEMENT, LLC4.9M$591.3Mincreased
Invesco Ltd.4.1M$502.0Mincreased
LSV ASSET MANAGEMENT3.9M$471.0M—
WELLINGTON MANAGEMENT GROUP LLP3.4M$407.8Mdecreased
RENAISSANCE TECHNOLOGIES LLC3.3M$403.7Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by INCY insiders, by quarter · Form 4
-500.0K-250.0K0250.0K500.0K2025 Q1: -46.8K2025 Q12025 Q2: -3,4092025 Q22025 Q3: -49.3K2025 Q32025 Q4: -292.0K2025 Q42026 Q1: -63.8K2026 Q12026 Q2: -38.4K2026 Q22026 Q3: -152.7K2026 Q32026 Q4: -257.4K2026 Q4

Recent Insider Transactions

2,717 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Stein Steven HCMO & Head of Late-Stage Dev. Sale −576 $121.98 $70K Nov 16, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Sale −877 $121.98 $107K Nov 16, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Sale −1,765 $120.46 $213K Nov 16, 2026 Form 4 ↗
Heeson LeeEVP, Head of Incyte Intl Sale −874 $121.16 $106K Nov 13, 2026 Form 4 ↗
Heeson LeeEVP, Head of Incyte Intl Sale −3,700 $120.33 $445K Nov 13, 2026 Form 4 ↗
Heeson LeeEVP, Head of Incyte Intl Sale −2,449 $121.13 $297K Nov 13, 2026 Form 4 ↗
Heeson LeeEVP, Head of Incyte Intl Sale −2,200 $120.44 $265K Nov 13, 2026 Form 4 ↗
Heeson LeeEVP, Head of Incyte Intl Sale −1,471 $121.89 $179K Nov 13, 2026 Form 4 ↗
Stein Steven HCMO & Head of Late-Stage Dev. Sale −74.0K $119.12 $8.8M Nov 6, 2026 Form 4 ↗
Stein Steven HCMO & Head of Late-Stage Dev. Sale −60.3K $118.27 $7.1M Nov 6, 2026 Form 4 ↗
Stein Steven HCMO & Head of Late-Stage Dev. Sale −48.6K $119.66 $5.8M Nov 6, 2026 Form 4 ↗
Stein Steven HCMO & Head of Late-Stage Dev. Sale −35.0K $116.06 $4.1M Nov 6, 2026 Form 4 ↗
Stein Steven HCMO & Head of Late-Stage Dev. Sale −22.3K $117.14 $2.6M Nov 6, 2026 Form 4 ↗
Tray ThomasPrincipal Accounting Officer Sale −610 $118.96 $73K Nov 3, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Sale −2,642 $112.71 $298K Oct 15, 2026 Form 4 ↗
Gardner David HEVP, Chief Strategy Officer Tax withholding −920 $126.93 $117K Sep 22, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Sale −14.0K $120.49 $1.7M Sep 15, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Sale −9,233 $120.50 $1.1M Sep 15, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Option exercise +9,233 $71.93 $664K Sep 15, 2026 Form 4 ↗
CAGNONI PABLO JPresident, Global Head of R&D Option exercise +6,477 $64.25 $416K Sep 15, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding INCY · SEC Form N-PORT
FundSharesValue% of fundAs of
Dodge & Cox Stock Fund
Dodge & Cox Funds
8.0M$901.6M0.76%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
5.4M$611.1M0.03%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
4.3M$492.8M0.03%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
3.9M$441.5M0.23%Jun 30, 2026
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
2.4M$285.2M0.75%Jul 31, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
2.2M$268.4M0.03%Aug 31, 2026
iShares Core S&P 500 ETF
iShares Trust
2.3M$261.8M0.03%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
2.2M$254.6M0.54%Jun 30, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust2.0M$228.9M0.03%Jun 30, 2026
Invesco S&P 500 Equal Weight ETF
Invesco Exchange-Traded Fund Trust
1.8M$211.3M0.22%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list INCY's shares (CUSIP 45337C102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Dodge & CoxSCHEDULE 13G/A · passive (13G) · 10.1M shares5.0%
    Nov 12, 2026 · ↗
  • Dodge & CoxSCHEDULE 13G/A · passive (13G) · 12.3M shares6.2%
    May 14, 2026 · ↗
  • FBB AssociatesSCHEDULE 13D/A · activist (13D) · 33.4K shares0.0%
    May 11, 2026 · ↗
  • FBB3 LLCSCHEDULE 13D/A · activist (13D) · 31.1K shares0.0%
    May 11, 2026 · ↗
  • FBB2, LLCSCHEDULE 13D/A · activist (13D) · 14.8K shares0.0%
    May 11, 2026 · ↗
  • Felix J. BakerSCHEDULE 13D/A · activist (13D) · 31.2M shares15.6%
    May 11, 2026 · ↗
  • Julian C. BakerSCHEDULE 13D/A · activist (13D) · 31.2M shares15.6%
    May 11, 2026 · ↗
  • Baker Bros. Advisors (GP) LLCSCHEDULE 13D/A · activist (13D) · 30.9M shares15.4%
    May 11, 2026 · ↗
  • Baker Bros. Advisors LPSCHEDULE 13D/A · activist (13D) · 30.9M shares15.4%
    May 11, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming incyte as client
$0$1.3M$2.5M$3.8M$5.0M2023 Q1: $530K2023 Q2: $400K2023 Q3: $540K2023 Q4: $990K20232024 Q1: $380K2024 Q2: $480K2024 Q3: $400K2024 Q4: $770K20242025 Q1: $430K2025 Q2: $720K2025 Q3: $600K2025 Q4: $870K20252026 Q1: $840K2026 Q2: $1.2M2026 Q3: $690K2026
  • AVENUE SOLUTIONSINCYTE CORPORATION · 2026 Q3 · HCR, MMM$60K
    Filing ↗
  • W STRATEGIES, LLCINCYTE CORPORATION · 2026 Q3 · MMM$60K
    Filing ↗
  • INCYTE CORPORATIONINCYTE CORPORATION · 2026 Q3 · MMM$380K
    Filing ↗
  • TIBER CREEK GROUPINCYTE CORPORATION · 2026 Q3 · MMM, HCR$80K
    Filing ↗
  • LMH STRATEGIC SOLUTIONSINCYTE CORPORATION · 2026 Q2 · HCR, PHA$50K
    Filing ↗

Government Contracts

Federal awards to INCYTE CORP · USAspending

No federal contract awards found for INCYTE CORP.

U.S. Patents

Recent USPTO applications naming INCYTE CORP

No USPTO patent applications found for INCYTE CORP.

Annual Financials

From INCY's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$5.14B$4.24B$3.70B$3.39B$2.99B
Operating income$1.51B$61.4M$620.5M$579.4M$585.8M
Net income$1.29B$32.6M$597.6M$340.7M$948.6M
Diluted EPS$6.41$0.15$2.65$1.52$4.27
Operating cash flow$1.41B$335.3M$496.5M$969.9M$749.5M
Cash and equivalents$3.10B$1.69B$3.21B$2.95B$2.06B
Total assets$6.96B$5.44B$6.78B$5.84B$4.93B
Total liabilities$1.79B$2.00B$1.59B$1.47B$1.16B
Shareholders' equity$5.17B$3.45B$5.19B$4.37B$3.77B

As INCYTE CORP tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 10, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitSep 1, 2000
  • 2-for-1Stock splitNov 10, 1997

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 8.01Other eventsNov 13, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsOct 29, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsAug 31, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 28, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsJul 6, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 22, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 9, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 8, 2026
    EDGAR ↗

About INCYTE CORP

From SEC EDGAR company records
Industry (SIC 8731)Services-Commercial Physical & Biological Research
SectorIndustrials
HeadquartersWILMINGTON, DE
IncorporatedDE
Former namesINCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC